| Wall Street Journal. Europe 2001 Gardiner Harris |
| Title | Subject | Authors |
|---|
| Bristol-Myers, Novartis bid for DuPont's drug business. | Business, international | Susan Warren, Anita Raghavan, Gardiner Harris |
| Bristol nears deal for DuPont unit, but side issues remain outstanding (Bristol-Myers Squibb Co., bids for DuPont Pharmaceuticals). | Business, international | Susan Warren, Gardiner Harris, Nikhil Deogun |
| Johnson & Johnson, Merck post growth on drug sales rise. | Business, international | Gardiner Harris, Scott Hensley |
| Merck acquires drug researcher in equity deal. | Business, international | Gardiner Harris, Antonio Regalado |
| Merck, Schering-Plough, AHP suffer setbacks, and stocks fall.(Slump shows problem with relying on blockbuster drugs.) | Business, international | Gardiner Harris, Geeta Anand |
| Merck's net rose 5% in quarter, meeting estimates.(2001) | Business, international | Gardiner Harris |
| Merck warns of flat results next year on Vioxx letdown. | Business, international | Gardiner Harris |
| President to leave Schering-Plough by July 15. | Business, international | Gardiner Harris |
| Schering-Plough could face fine of $500 million to settle U.S. probe. | Business, international | Gardiner Harris |
| Schering-Plough expects flat period results. | Business, international | Gardiner Harris |
| U.S. drug makers report mixed first-quarter results. | Business, international | Gardiner Harris, Scott Hensley |
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
